Screener
Eligibility screening
Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors
4 US sites in AL, FL, NJ, VA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors
4 US sites in AL, FL, NJ, VA
Before we begin
Your answer affects how the questions are phrased.